Clinical Trial Update: Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating DLBS3233 for efficacy and safety in Polycystic Ovary Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• DLBS3233

Snippet

Sponsor: Dexa Medica Group | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 3 | Status: COMPLETED